You are here

Home » Content

DRUG UTILIZATION STUDY IN PELVIC INFLAMMATORY DISEASE IN A TEACHING HOSPITAL IN NORTH INDIA

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
The study was carried out in the OPD (out-Patients) of Teerthanker Mahaveer Medical college, Hospital & Research Centre, a 550-bedded teaching hospital situated in Moradabad, U.P, India. It was a prospective study and was based on medication utilization form, which has been designed on the basis of a WHO format. It contained patient particulars, diagnosis, investigations, drug details and information from the prescriber regarding the indication for prescribing agents (both topical and oral), underlying infection, duration of therapy and details of any concomitant medications. The information was compiled and analyzed in consultation with the concerned consultant. The duration of study was 12 months (January 2012 to February 2013). The study was approved by the Institutional Ethical Committee. An oral and written consent was obtained from the patients before their participitation in the study. The purpose of this study was to: a. Evaluate the quality of the prescriptions in terms of the adequacy, effectivity and clarity of the information contained, and number of medicines prescribed by doctor to achieve rationale medical care b. Bring about improvement in the practical training of medical students in teaching hospitals so that better treatment policy can be outlined for the benefit of such patients, doctors and students being trained in that hospital.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-drug-utilization-study-pelvic-inflammatory-disease-teaching-hospital-north-india.pdf
  • 4
152
167
  • English

REFERENCES

References: 

1. Loscalzo, Joseph; Andreoli, Thomas E.; Cecil, Russell L.; Carpenter, Charles A.; Griggs, Robert C. (2001). Cecil essentials of medicine. Philadelphia: W.B. Saunders. ISBN 0-7216-8179-4. OCLC 43051599.
2. Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort. British Journal of Obstetrics & Gynaecology 1995; 102:407¬14.
3. Recommendations arising from the 31st Study Group: The Prevention of Pelvic infection. in Templeton A, ed. The prevention of pelvic, pp 267-70. London:RCOG Press, 1996.
4. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK et al. Association between Mycoplasma genitalium and acute endometritis. Lancet
2002; 359: 765-6.
165
Available Online at www.ijprbs.com
Research
Articl
e CODEN: IJPRNK
Sanjeev Sharma, IJPRBS, 2013; Volume 2(4): 152-167
5. CDC. Sexually Transmitted Diseases Treatment Guidelines 2002. MMWR -Morbidity & Mortality Weekly Report 2002; 55: 1-84.
6. Bongard F, Landers DV, Lewis F. Differential diagnosis of appendicitis and pelvic inflammatory disease. A prospective analysis. American Journal of Surgery. 1985; 150: 90-6.
7. Pelvic Inflammatory Disease treatment at eMedicine
8. Arredondo JL, Diaz V, Gaitan H, Maradiegue E, Oyarzun E, Paz R et al. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Clin.Infect.Dis. 1997; 24: 170¬8.
9. Hemsell DL, Little BB, Faro S, Sweet RL, Ledger WJ, Berkeley AS et al. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin.Infect.Dis.
1994; 19: 720-7.
10. Martens MG, Gordon S, Yarborough DR, Faro S, Binder D, Berkeley A. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. Southern Medical Journal 1993; 86: 604-10.
ISSN: 2277-8713
IJPRBS
11. The European Study Group. Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. Acta Obstetricia et Gynecologica Scandinavica 1992;71:129-
34.
12. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. Journal of Infectious Diseases 1993; 168: 969-78.
13. Peipert JF, Sweet RL, Walker CK, Kahn J, Rielly-Gauvin K. Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis). Infectious Diseases in Obstetrics & Gynecology 1999;7:138-44.
14. Witte EH, Peters AA, Smit IB, van
de
r Linden MC, Mouton RP, van der Mee et al. A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease. European Journal of Obstetrics, Gynecology, & Reproductive Biology 1993;
50: 153-8.
15. Baksaas, Lunde PKM: National drug policies: the need for drug utilisation studies. Trends in Pharmacological Sciences 9:331. 1986.
16. Peipert JF, Sweet RL, Walker CK, Kahn J, Rielly-Gauvin K. Evaluation of ofloxacin
Available Online at www.ijprbs.com
166
Research
Articl
e CODEN: IJPRNK
Sanjeev Sharma, IJPRBS, 2013; Volume 2(4): 152-167
ISSN: 2277-8713
IJPRBS
in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis). Infectious Diseases in Obstetrics & Gynecology 1999; 7: 138-44.
17. Witte EH, Peters AA, Smit IB, van
de
r Linden MC, Mouton RP, van der Mee et al. A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease. European Journal of Obstetrics, Gynecology, & Reproductive Biology 1993;
50: 153-8.
18. Baksaas, Lunde PKM : National drug policies: the need for drug utilisation studies. Trends in Pharmacological Sciences 9:331. 1986.

Thank you for copying data from http://www.arastirmax.com